Trade Summary

6 days ago, Driscoll Michael Joseph, serving as Dir at Organogenesis Holdings Inc. (ORGO), purchased 10,000 shares at $2.67 per share, for a total transaction value of $26,688.00. Following this transaction, Driscoll Michael Joseph now holds 225,707 shares of ORGO.

This purchase represents a 5.00% increase in Driscoll Michael Joseph's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, 2 days after the trade was made.

Organogenesis Holdings Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.